In this respect our present data, together with our previous work indicating the critical role of PLCγ1 in metastasis development and progression [30] suggest that targeting PLCγ1 may represent a useful strategy to inhibit metastasis growth and possibly tumour angiogenesis simultaneously. The gene discussed is PLCG1; the disease is neoplasm.